WebOur initial research protocol consists of low-dose psilocybin functional MRI experiments to obtain a deeper understanding of the neural correlates of the psychedelic experience. This study protocol received FDA approval in January 2024 and the campus’ Institutional Review Board approval in May 2024. WebOur Board of Directors bring a wealth of valuable experience in drug development, capital markets, and investment management activities. Gage Jull Chairman James Kuo, MD Director & Co-Founder David Tousley Director Chris Ntoumenopoulos
Discover More in Psychedelics on Flipboard
WebJun 17, 2024 · Oregon’s Psilocybin Advisory Board convened earlier this year and is currently learning about the safety and efficacy of psilocybin in treating a variety of mental health … WebMar 30, 2024 · Massachusetts General Hospital has launched a program to study how psychedelic drugs can affect the brain and potentially treat mental illness. feeding baby quail
Discover More in Psychedelics on Flipboard
WebDec 1, 1970 · Editorial Board Advertising and Corporate Services Self-Archiving Policy Dispatch Dates ... This paper is not concerned with the very real problems of drug abuse, or laws on psychedelic drugs and the need for a fresh look at them, or the need for research in this area. It neither proposes nor tries to prove a particular inner-cycle pattern ... WebMar 23, 2024 · CEO and board member Ronan Levy resigned has resigned from his role at the company while board member Keith Merker assumed the role of chief restructuring officer. Advertisement Toronto-based Field Trip Health & Wellness offers therapy enhanced by micro-dosing the anesthetic ketamine in clinics and, for a brief time, in patients’ homes … WebAug 3, 2024 · Aug. 3, 2024 6 a.m. A state advisory board says the active ingredient in hallucinogenic mushrooms, psilocybin, shows promise for mental health therapy. In a new report, the board cites a number of ... feeding baby rice cereal 4 months